title: Identification of trace-amine-associated receptors (TAAR) in the rat aorta and their role in vasoconstriction by β-phenylethylamine.
abstract: Trace amines including tyramine and β-phenylethylamine (β-PEA) increase blood pressure and cause vasoconstriction which is attributed to indirect sympathomimetic actions. However, there is evidence that they may also have non-sympathomimetic mechanisms. This study examined whether β-PEA causes vasoconstriction of rat aorta by a sympathomimetic action or through the recently described trace-amine-associated receptors (TAAR). Concentration-response curves (CRCs) for β-PEA were constructed either cumulatively or non-cumulatively in rat isolated aortic rings. TAAR-1 and TAAR-4 protein expression was determined in rat aorta by Western blotting and TAAR-1 mRNA by reverse transcriptase polymerase chain reaction (RT-PCR). β-PEA caused concentration-related constriction of rat aorta. The contractions were unaffected by endothelium removal or the nitric oxide synthase inhibitor, N(ω)-nitro-L-arginine methyl ester (L-NAME, 100 μM) or the cyclooxygenase inhibitor, indomethacin (10 μM). Non-cumulative CRCs showed greater contractions and sensitivity to β-PEA than cumulative. The α(1)-adrenoceptor antagonist, prazosin, failed to inhibit either curve. The β-adrenoceptor antagonist, propranolol, the adrenergic neuronal transport inhibitor, cocaine, and the monoamine oxidase inhibitor, pargyline, also failed to alter the CRC. In the combined presence of prazosin, cocaine, pargyline, and the selective β(2)-adrenoceptor antagonist, ICI-118,551, the trace amine contractile potency order was tryptamine > β-PEA > octopamine > D: -amphetamine > tyramine. Western blotting and RT-PCR revealed the presence of TAAR-1 in rat aorta, but TAAR-4 was poorly expressed. Vasoconstriction of rat aorta by β-PEA appears not to be an indirect sympathomimetic action. The presence of TAAR-1 suggests that vasoconstriction may be via these receptors; however, the potency order differed from that reported for transfected cells expressing rat TAAR-1.
authors.affiliation: Welsh School of Pharmacy, Cardiff University, Cardiff, South Wales, CF10 3NB, UK.
authors.forename: Martina
authors.initials: M
authors.lastname: Fehler
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Broadley
authors.forename: William R
authors.initials: WR
authors.lastname: Ford
authors.forename: Emma J
authors.initials: EJ
authors.lastname: Kidd
mesh_terms: D000818:Animals; D001012:Aorta, Abdominal / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D001013:Aorta, Thoracic / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D015153:Blotting, Western; D004305:Dose-Response Relationship, Drug; D066298:In Vitro Techniques; D008297:Male; D010627:Phenethylamines / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014661:Vasoconstriction / Q000187:drug effects*; D000095383:Trace Amine-Associated Receptors
chemical_list: D010627:Phenethylamines; D043562:Receptors, G-Protein-Coupled; D000095383:Trace Amine-Associated Receptors; C029261:phenethylamine
references.citation: Can J Physiol Pharmacol. 1995 Jun;73(6):742-6
references.pmid: 7585347
references.citation: Pharmacol Ther. 2010 Mar;125(3):363-75
references.pmid: 19948186
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1991 Feb;343(2):143-8
references.pmid: 2067587
references.citation: Cardiovasc Res. 2006 Jan;69(1):128-39
references.pmid: 16225854
references.citation: J Food Prot. 2008 Jan;71(1):205-9
references.pmid: 18236686
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):8966-71
references.pmid: 11459929
references.citation: J Pharmacol Exp Ther. 1971 Mar;176(3):672-83
references.pmid: 5111455
references.citation: J Pharmacol Exp Ther. 1988 Oct;247(1):143-9
references.pmid: 2971796
references.citation: AAPS J. 2006 Mar 10;8(1):E138-45
references.pmid: 16584120
references.citation: Life Sci. 1984 Jul 2;35(1):71-7
references.pmid: 6738305
references.citation: J Pharmacol Exp Ther. 1991 Aug;258(2):669-75
references.pmid: 1865363
references.citation: Mol Pharmacol. 2001 Dec;60(6):1181-8
references.pmid: 11723224
references.citation: Genomics. 2005 Mar;85(3):372-85
references.pmid: 15718104
references.citation: Pediatr Allergy Immunol. 2002 Feb;13(1):10-7
references.pmid: 12000493
references.citation: Drugs. 1983 Apr;25(4):339-84
references.pmid: 6303744
references.citation: J Alzheimers Dis. 2006 Dec;10(4):379-90
references.pmid: 17183149
references.citation: J Pharmacol Exp Ther. 1966 Jul;153(1):70-80
references.pmid: 4288397
references.citation: J Neural Transm Suppl. 1998;52:39-48
references.pmid: 9564606
references.citation: Br J Pharmacol Chemother. 1967 Aug;30(3):631-43
references.pmid: 6050502
references.citation: J Pharmacol Exp Ther. 1986 May;237(2):473-7
references.pmid: 3009787
references.citation: J Pharmacol Exp Ther. 1984 Mar;228(3):733-8
references.pmid: 6323680
references.citation: J Pharmacol Exp Ther. 1993 Jun;265(3):1096-104
references.pmid: 8389852
references.citation: J Pharmacol Exp Ther. 1972 Aug;182(2):264-72
references.pmid: 5048363
references.citation: Phytother Res. 2002 Aug;16(5):403-13
references.pmid: 12203257
references.citation: J Cardiovasc Pharmacol. 1983 May-Jun;5(3):430-7
references.pmid: 6191142
references.citation: J Neurochem. 2004 Jul;90(2):257-71
references.pmid: 15228583
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1989 Apr;339(4):433-40
references.pmid: 2500604
references.citation: Eur J Pharmacol. 2006 May 1;536(3):279-86
references.pmid: 16584727
references.citation: Vascul Pharmacol. 2007 Jul;47(1):10-7
references.pmid: 17459782
references.citation: Pharmacol Biochem Behav. 2002 Apr;71(4):533-54
references.pmid: 11888546
references.citation: Trends Pharmacol Sci. 2005 May;26(5):274-81
references.pmid: 15860375
references.citation: Int J Food Microbiol. 2003 Nov 15;88(1):41-54
references.pmid: 14527784
references.citation: Eur J Pharmacol. 2008 Jun 10;587(1-3):231-6
references.pmid: 18486124
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2009 Apr;379(4):385-8
references.pmid: 19172248
references.citation: Rev Esp Fisiol. 1989 Mar;45(1):79-88
references.pmid: 2748979
references.citation: Biochem Pharmacol. 1996 Jul 26;52(2):341-9
references.pmid: 8694859
references.citation: Nat Med. 2004 Jun;10(6):638-42
references.pmid: 15146179
references.citation: Anesth Analg. 2000 Mar;90(3):625-31
references.pmid: 10702448
references.citation: Br J Pharmacol. 2008 Oct;155(4):525-34
references.pmid: 18604230
references.citation: Prog Neurobiol. 2006 Aug;79(5-6):223-46
references.pmid: 16962229
references.citation: Br J Nutr. 2009 Jun;101(11):1645-52
references.pmid: 19017420
references.citation: Br J Pharmacol. 2000 Feb;129(4):637-44
references.pmid: 10683187
references.citation: J Pharmacol Exp Ther. 1987 Mar;240(3):764-71
references.pmid: 3559972
references.citation: Br J Pharmacol. 1990 Nov;101(3):746-52
references.pmid: 1706208
references.citation: FEMS Microbiol Lett. 2006 May;258(1):144-9
references.pmid: 16630269
references.citation: Auton Autacoid Pharmacol. 2003 Oct-Dec;23(5-6):319-26
references.pmid: 15255816
references.citation: Curr Opin Pharmacol. 2003 Feb;3(1):90-7
references.pmid: 12550748
references.citation: Proc Natl Acad Sci U S A. 1980 Mar;77(3):1706-10
references.pmid: 6929517
references.citation: Am J Physiol. 1997 Sep;273(3 Pt 2):H1478-83
references.pmid: 9321840
references.citation: Br J Pharmacol. 1984 Apr;81(4):637-44
references.pmid: 6144344
references.citation: Br J Pharmacol. 2006 Dec;149(8):967-78
references.pmid: 17088868
references.citation: Comp Gen Pharmacol. 1973 Jun;4(14):131-8
references.pmid: 4770271